Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Attenuation of early phase inflammation by cannabidiol prevents pain and nerve damage in rat osteoarthritis.

Philpott HT, OʼBrien M, McDougall JJ.

Pain. 2017 Dec;158(12):2442-2451. doi: 10.1097/j.pain.0000000000001052.

2.

Single and combined effects of Δ9 -tetrahydrocannabinol and cannabidiol in a mouse model of chemotherapy-induced neuropathic pain.

King KM, Myers AM, Soroka-Monzo AJ, Tuma RF, Tallarida RJ, Walker EA, Ward SJ.

Br J Pharmacol. 2017 Sep;174(17):2832-2841. doi: 10.1111/bph.13887. Epub 2017 Jul 27.

3.

Effects of Delta-9-Tetrahydrocannabinol and Cannabidiol on Cisplatin-Induced Neuropathy in Mice.

Harris HM, Sufka KJ, Gul W, ElSohly MA.

Planta Med. 2016 Aug;82(13):1169-72. doi: 10.1055/s-0042-106303. Epub 2016 May 23.

PMID:
27214593
4.

Medicinal cannabis.

Murnion B.

Aust Prescr. 2015 Dec;38(6):212-5. Epub 2015 Dec 1. Review.

5.

Role of the endocannabinoid system in diabetes and diabetic complications.

Gruden G, Barutta F, Kunos G, Pacher P.

Br J Pharmacol. 2016 Apr;173(7):1116-27. doi: 10.1111/bph.13226. Epub 2015 Aug 20. Review.

6.

Neuroprotection and reduction of glial reaction by cannabidiol treatment after sciatic nerve transection in neonatal rats.

Perez M, Benitez SU, Cartarozzi LP, Del Bel E, Guimarães FS, Oliveira AL.

Eur J Neurosci. 2013 Nov;38(10):3424-34. doi: 10.1111/ejn.12341. Epub 2013 Aug 25.

PMID:
23981015
7.

A double-blind, placebo-controlled, crossover pilot trial with extension using an oral mucosal cannabinoid extract for treatment of chemotherapy-induced neuropathic pain.

Lynch ME, Cesar-Rittenberg P, Hohmann AG.

J Pain Symptom Manage. 2014 Jan;47(1):166-73. doi: 10.1016/j.jpainsymman.2013.02.018. Epub 2013 Jun 4.

PMID:
23742737
8.

The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complications.

Horváth B, Mukhopadhyay P, Haskó G, Pacher P.

Am J Pathol. 2012 Feb;180(2):432-42. doi: 10.1016/j.ajpath.2011.11.003. Epub 2011 Dec 5. Review.

9.

Cannabidiol prevents the development of cold and mechanical allodynia in paclitaxel-treated female C57Bl6 mice.

Ward SJ, Ramirez MD, Neelakantan H, Walker EA.

Anesth Analg. 2011 Oct;113(4):947-50. doi: 10.1213/ANE.0b013e3182283486. Epub 2011 Jul 7.

10.

Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain.

Toth CC, Jedrzejewski NM, Ellis CL, Frey WH 2nd.

Mol Pain. 2010 Mar 17;6:16. doi: 10.1186/1744-8069-6-16.

11.
12.

Antihyperalgesic effect of a Cannabis sativa extract in a rat model of neuropathic pain: mechanisms involved.

Comelli F, Giagnoni G, Bettoni I, Colleoni M, Costa B.

Phytother Res. 2008 Aug;22(8):1017-24. doi: 10.1002/ptr.2401.

PMID:
18618522
13.

The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain.

Costa B, Trovato AE, Comelli F, Giagnoni G, Colleoni M.

Eur J Pharmacol. 2007 Feb 5;556(1-3):75-83. Epub 2006 Nov 10.

PMID:
17157290
14.

GW-1000. GW Pharmaceuticals.

Smith PF.

Curr Opin Investig Drugs. 2004 Jul;5(7):748-54.

PMID:
15298072
15.

Supplemental Content

Loading ...
Support Center